Suchergebnisse - "Del Rio, Carlos"

PubPharm (7)

1

Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding : a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Landovitz, R. | Hanscom, B. | Clement, M. | +28

CommentIn: Lancet HIV. 2023 Dec;10(12):e756-e757. - PMID 37952552

2

Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women : a secondary analysis of the HPTN 083 trial

enthalten in: The lancet. HIV | 2023

von Marzinke, M. | Hanscom, B. | Wang, Z. | +71

CommentIn: Lancet HIV. 2023 Nov;10(11):e694-e695. - PMID 37783220

3

Mexican perspective on the Mosaico HIV vaccine trial

enthalten in: The lancet. HIV | 2023

von Crabtree Ramírez, B. | González Hernández, L. | Cabrera, C. | +3

4

Improving health equity and ending the HIV epidemic in the USA : a distributional cost-effectiveness analysis in six cities

enthalten in: The lancet. HIV | 2021

von Quan, A. | Mah, C. | Krebs, E. | +27

5

Ending the HIV epidemic in the USA : an economic modelling study in six cities

enthalten in: The lancet. HIV | 2020

von Nosyk, B. | Zang, X. | Krebs, E. | +31

CommentIn: Lancet HIV. 2020 Jul;7(7):e454-e455. - PMID 32145761

6

Effect of the US National HIV/AIDS Strategy targets for improved HIV care engagement : a modelling study

enthalten in: The lancet. HIV | 2016

von Shah, M. | Perry, A. | Risher, K. | +7

CommentIn: Lancet HIV. 2016 Mar;3(3):e109-10. - PMID 26939733

7

Understanding the HIV disparities between black and white men who have sex with men in the USA using the HIV care continuum : a modeling study

enthalten in: The lancet. HIV | 2014

von Rosenberg, E. | Millett, G. | Sullivan, P. | +2

1
[1]